Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' GELBOIN HV' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 68 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Krausz, KW; Goldfarb, I; Buters, JTM; Yang, TJ; Gonzalez, FJ; Gelboin, HV
      Monoclonal antibodies specific and inhibitory to human cytochromes P4502C8, 2C9, and 2C19

      DRUG METABOLISM AND DISPOSITION
    2. Niemela, O; Parkkila, S; Juvonen, RO; Viitala, K; Gelboin, HV; Pasanen, M
      Cytochromes P450 2A6 2E1, and 3A and production of protein-aldehyde adducts in the liver of patients with alcoholic and non-alcoholic liver diseases

      JOURNAL OF HEPATOLOGY
    3. Krausz, KW; Goldfarb, I; Yang, TJ; Gonzalez, FJ; Gelboin, HV
      An inhibitory monoclonal antibody to human cytochrome P450 that specifically binds and inhibits P4502C9II, an allelic variant of P4502C9 having a single amino acid change Arg144 Cys

      XENOBIOTICA
    4. Sai, Y; Dai, R; Yang, TJ; Krausz, KW; Gonzalez, FJ; Gelboin, HV; Shou, M
      Assessment of specificity of eight chemical inhibitors using cDNA-expressed cytochromes P450

      XENOBIOTICA
    5. Shou, MG; Lu, T; Krausz, KW; Sai, Y; Yang, TJ; Korzekwa, KR; Gonzalez, FJ; Gelboin, HV
      Use of inhibitory monoclonal antibodies to assess the contribution of cytochromes P450 to human drug metabolism

      EUROPEAN JOURNAL OF PHARMACOLOGY
    6. Cai, YN; Marcus, C; Guengerich, FP; Gelboin, HV; Baird, WM
      Role of cytochrome P450 1A1 and 1B1 in metabolic activation of dibenzo[a,l]pyrene by microsomes from the human mammary carcinoma cell line MCF-7

      POLYCYCLIC AROMATIC COMPOUNDS
    7. Sai, Y; Yang, TJ; Krausz, KW; Gonzalez, FJ; Gelboin, HV
      An inhibitory monoclonal antibody to human cytochrome P450 2A6 defines itsrole in the metabolism of coumarin, 7-ethoxycoumarin and 4-nitroanisole inhuman liver

      PHARMACOGENETICS
    8. Yang, TJ; Krausz, KW; Sai, Y; Gonzalez, FJ; Gelboin, HV
      Eight inhibitory monoclonal antibodies define the role of individual P-450S in human liver microsomal diazepam, 7-ethoxycoumarin, and imipramine metabolism

      DRUG METABOLISM AND DISPOSITION
    9. Miyata, M; Kudo, G; Lee, YH; Yang, TJ; Gelboin, HV; Fernandez-Salguero, P; Kimura, S; Gonzalez, FJ
      Targeted disruption of the microsomal epoxide hydrolase gene - Microsomal epoxide hydrolase is required for the carcinogenic activity of 7,12-dimethylbenz[a]anthracene

      JOURNAL OF BIOLOGICAL CHEMISTRY
    10. Chen, SC; Wang, XJ; Xu, GP; Zhou, L; Vennerstrom, JL; Gonzalez, F; Gelboin, HV; Mirvish, SS
      Depentylation of [H-3-pentyl]methyl-n-amylnitrosamine by rat esophageal and liver microsomes and by rat and human cytochrome p450 isoforms

      CANCER RESEARCH
    11. Gelboin, HV; Krausz, KW; Gonzalez, FJ; Yang, TJ
      Inhibitory monoclonal antibodies to human cytochrome P450 enzymes: a new avenue for drug discovery

      TRENDS IN PHARMACOLOGICAL SCIENCES
    12. YANG TJ; SAI Y; KRAUSZ KW; GONZALEZ FJ; GELBOIN HV
      INHIBITORY MONOCLONAL-ANTIBODIES TO HUMAN CYTOCHROME-P450 1A2 - ANALYSIS OF PHENACETIN O-DEETHYLATION IN HUMAN LIVER

      Pharmacogenetics
    13. SHOU MG; MARTINET M; KORZEKWA KR; KRAUSZ KW; GONZALEZ FJ; GELBOIN HV
      ROLE OF HUMAN CYTOCHROME-P450 3A4 AND 3A5 IN THE METABOLISM OF TAXOTERE AND ITS DERIVATIVES - ENZYME SPECIFICITY, INTERINDIVIDUAL DISTRIBUTION AND METABOLIC CONTRIBUTION IN HUMAN LIVER

      Pharmacogenetics
    14. SHOU M; LU T; MEI Q; RUSHMORE T; BAILLIE TA; GONZALEZ FJ; GELBOIN HV
      USING MONOCLONAL-ANTIBODIES TO ASSESS THE CONTRIBUTION OF INDIVIDUAL CYTOCHROME P450S TO DRUG-METABOLISM IN HUMAN LIVER

      The FASEB journal
    15. SAI Y; DAI R; YANG T; RUSHMORE T; BAILLIE TA; GONZALEZ FJ; GELBOIN HV; SHOU M
      INHIBITION-KINETICS OF MONOCLONAL-ANTIBODIES AGAINST CYTOCHROME P450-MEDIATED DRUG-METABOLISM

      The FASEB journal
    16. EKINS S; VANDENBRANDEN M; RING BJ; GILLESPIE JS; YANG TJ; GELBOIN HV; WRIGHTON SA
      FURTHER CHARACTERIZATION OF THE EXPRESSION IN LIVER AND CATALYTIC ACTIVITY OF CYP2B6

      The Journal of pharmacology and experimental therapeutics
    17. YANG TJ; SHOU M; KORZEKWA KR; GONZALEZ FJ; GELBOIN HV; YANG SK
      ROLE OF CDNA-EXPRESSED HUMAN CYTOCHROMES P450 IN THE METABOLISM OF DIAZEPAM

      Biochemical pharmacology
    18. ZAHER H; YANG TJ; GELBOIN HV; FERNANDEZSALGUERO P; GONZALEZ FJ
      EFFECT OF PHENOBARBITAL ON HEPATIC CYP1A1 AND CYP1A2 IN THE AHR-NULL MOUSE

      Biochemical pharmacology
    19. YANG TJ; KRAUSZ KW; SHOU MG; YANG SK; BUTERS JTM; GONZALEZ FJ; GELBOIN HV
      INHIBITORY MONOCLONAL-ANTIBODY TO HUMAN CYTOCHROME-P450 2B6

      Biochemical pharmacology
    20. GELBOIN HV; KRAUSZ KW; SHOU M; GONZALEZ FJ; YANG TJ
      A MONOCLONAL-ANTIBODY INHIBITORY TO HUMAN P450 2D6 - A PARADIGM FOR USE IN COMBINATORIAL DETERMINATION OF INDIVIDUAL P450 ROLE IN SPECIFIC DRUG TISSUE METABOLISM

      Pharmacogenetics
    21. EINOLF HJ; STORY WT; MARCUS CB; LARSEN MC; JEFCOATE CR; GREENLEE WF; YAGI H; JERINA DM; AMIN S; PARK SS; GELBOIN HV; BAIRD WM
      ROLE OF CYTOCHROME-P450 ENZYME-INDUCTION IN THE METABOLIC-ACTIVATION OF BENZO[C]PHENANTHRENE IN HUMAN CELL-LINES AND MOUSE EPIDERMIS

      Chemical research in toxicology
    22. YANG TJ; KRAUSZ KW; SHOU MG; GONZALEZ FJ; GELBOIN HV
      A MONOCLONAL-ANTIBODY (MAB) INHIBITORY TO HUMAN P450 2D6 - A PARADIGMFOR DETERMINING AN INDIVIDUAL P450S ROLE IN THE TISSUE METABOLISM OF SPECIFIC DRUGS

      The FASEB journal
    23. SHOU MG; KORZEKWA KR; BROOKS EN; KRAUSZ KW; GONZALEZ FJ; GELBOIN HV
      ROLE OF HUMAN HEPATIC CYTOCHROME-P450 1A2 AND 3A4 IN THE METABOLIC-ACTIVATION OF ESTRONE

      Carcinogenesis
    24. KRAUSZ KW; YANG TJ; GONZALEZ FJ; SHOU MG; GELBOIN HV
      INHIBITORY MONOCLONAL-ANTIBODIES TO HUMAN CYTOCHROME-P450 2D6

      Biochemical pharmacology
    25. NAKAJIMA T; WANG RS; ELOVAARA E; GONZALEZ FJ; GELBOIN HV; RAUNIO H; PELKONEN O; VAINIO H; AOYAMA T
      TOLUENE METABOLISM BY CDNA-EXPRESSED HUMAN HEPATIC CYTOCHROME-P450

      Biochemical pharmacology
    26. KRAUL H; PASANEN M; SIGUSCH H; STENBACK F; PARK SS; GELBOIN HV; PELKONEN O
      IMMUNOHISTOCHEMICAL PROPERTIES OF DIPYRONE-INDUCED CYTOCHROMES P450 IN RATS

      Human & experimental toxicology
    27. BUTERS JTM; TANG BK; PINEAU T; GELBOIN HV; KIMURA S; GONZALEZ FJ
      ROLE OF CYP1A2 IN CAFFEINE PHARMACOKINETICS AND METABOLISM - STUDIES USING MICE DEFICIENT IN CYP1A2

      Pharmacogenetics
    28. SHOU MG; KORZEKWA KR; KRAUSZ KW; BUTERS JTM; GROGAN J; GOLDFARB I; HARDWICK JP; GONZALEZ FJ; GELBOIN HV
      SPECIFICITY OF CDNA-EXPRESSED HUMAN AND RODENT CYTOCHROME P450S IN THE OXIDATIVE-METABOLISM OF THE POTENT CARCINOGEN 7,12-DIMETHYLBENZ[A]ANTHRACENE

      Molecular carcinogenesis
    29. GELBOIN HV; GOLDFARB I; KRAUSZ KW; GROGAN J; KORZEKWA KR; GONZALEZ FJ; SHOU MG
      INHIBITORY AND NONINHIBITORY MONOCLONAL-ANTIBODIES TO HUMAN CYTOCHROME-P450 2E1

      Chemical research in toxicology
    30. GUT I; NEDELCHEVA V; SOUCEK P; STOPKA P; VODICKA P; GELBOIN HV; INGELMANSUNDBERG M
      THE ROLE OF CYP2E1 AND 2B1 IN METABOLIC-ACTIVATION OF BENZENE-DERIVATIVES

      Archives of toxicology
    31. PELLINEN P; STENBACK F; KOJO A; HONKAKOSKI P; GELBOIN HV; PASANEN M
      REGENERATIVE CHANGES IN HEPATIC MORPHOLOGY AND ENHANCED EXPRESSION OFCYP2B10 AND CYP3A DURING DAILY ADMINISTRATION OF COCAINE

      Hepatology
    32. SHOU MG; KRAUSZ KW; GONZALEZ FJ; GELBOIN HV
      METABOLIC-ACTIVATION OF THE POTENT CARCINOGEN DIBENZO[A,L]PYRENE BY HUMAN RECOMBINANT CYTOCHROMES P450, LUNG AND LIVER-MICROSOMES

      Carcinogenesis
    33. SHOU M; GONZALEZ FJ; GELBOIN HV
      STEREOSELECTIVE EPOXIDATION AND HYDRATION AT THE K-REGION OF POLYCYCLIC AROMATIC-HYDROCARBONS BY CDNA-EXPRESSED CYTOCHROMES P450 1A1, 1A2, AND EPOXIDE HYDROLASE

      Biochemistry
    34. OMAR RF; GELBOIN HV; RAHIMTULA AD
      EFFECT OF CYTOCHROME-P450 INDUCTION ON THE METABOLISM AND TOXICITY OFOCHRATOXIN-A

      Biochemical pharmacology
    35. SHOU MG; KRAUSZ KW; GONZALEZ FJ; GELBOIN HV
      METABOLIC-ACTIVATION OF THE POTENT CARCINOGEN DIBENZO[A,H]ANTHRACENE BY CDNA-EXPRESSED HUMAN CYTOCHROMES P450

      Archives of biochemistry and biophysics
    36. CRESPI CL; STEIMEL DT; PENMAN BW; KORZEKWA KR; FERNANDEZSALGUERO P; BUTERS JTM; GELBOIN HV; GONZALEZ FJ; IDLE JR; DALY AK
      COMPARISON OF SUBSTRATE METABOLISM BY WILD-TYPE CYP2D6 PROTEIN AND A VARIANT CONTAINING METHIONINE, NOT VALINE, AT POSITION-374

      Pharmacogenetics
    37. NAKAJIMA T; ELOVAARA E; OKINO T; GELBOIN HV; KLOCKARS M; RIIHIMAKI V; AOYAMA T; VAINIO H
      DIFFERENT CONTRIBUTIONS OF CYTOCHROME-P450 2E1 AND P450 2B1 2 TO CHLOROFORM HEPATOTOXICITY IN RAT/

      Toxicology and applied pharmacology
    38. MIRVISH SS; HUANG Q; WILLIAMSON J; CHEN SC; GELBOIN HV
      USE OF MONOCLONAL-ANTIBODIES TO CYTOCHROME P450S TO INDICATE THE CRITICAL DEALKYLATION AND THE P450S INVOLVED IN METHYL-N-AMYLNITROSAMINE MUTAGENICITY IN THE PRESENCE OF INDUCED RAT-LIVER MICROSOMES

      Mutation research
    39. POLZER RJ; COFFING SL; MARCUS CB; PARK SS; GELBOIN HV; BAIRD WM
      INHIBITION OF BENZO[A]PYRENE METABOLISM BY INSULIN, FITC-INSULIN AND AN FITC-INSULIN-ANTIBODY CONJUGATE IN THE HUMAN HEPATOMA-CELL LINE HEPG2

      Chemico-biological interactions
    40. GELBOIN HV; KRAUSZ KW; GOLDFARB I; BUTERS JTM; YANG SK; GONZALEZ FJ; KORZEKWA KR; SHOU MG
      INHIBITORY AND NONINHIBITORY MONOCLONAL-ANTIBODIES TO HUMAN CYTOCHROME-P450 3A3 4/

      Biochemical pharmacology
    41. SHOU MG; KORZEKWA KR; CRESPI CL; GONZALEZ FJ; GELBOIN HV
      THE ROLE OF 12-CDNA-EXPRESSED HUMAN, RODENT, AND RABBIT CYTOCHROMES-P450 IN THE METABOLISM OF BENZO[A]PYRENE AND BENZO[A]PYRENE TRANS-7,8-DIHYDRODIOL

      Molecular carcinogenesis
    42. NAKAJIMA T; ELOVAARA E; GONZALEZ FJ; GELBOIN HV; RAUNIO H; PELKONEN O; VAINIO H; AOYAMA T
      STYRENE METABOLISM BY CDNA-EXPRESSED HUMAN HEPATIC AND PULMONARY CYTOCHROMES P450

      Chemical research in toxicology
    43. TSYRLOV IB; GELBOIN HV
      A COEXPRESSION OF MAMMALIAN P450S AND NADPH-OXIDOREDUCTASE IN HUMAN-CELLS - ENZYME-KINETIC AND IMMUNOCHEMICAL STUDY

      The FASEB journal
    44. GONZALEZ FJ; GELBOIN HV
      ROLE OF HUMAN CYTOCHROMES P450 IN THE METABOLIC-ACTIVATION OF CHEMICAL CARCINOGENS AND TOXINS

      Drug metabolism reviews
    45. SHOU MS; KORZEKWA KR; KRAUSZ KW; CRESPI CL; GONZALEZ FJ; GELBOIN HV
      REGIOSELECTIVE AND STEREOSELECTIVE METABOLISM OF PHENANTHRENE BY 12 CDNA-EXPRESSED HUMAN, RODENT, AND RABBIT CYTOCHROMES P-450

      Cancer letters
    46. TSYRLOV IB; MIKHAILENKO VM; GELBOIN HV
      ISOZYME-SPECIFIC AND SPECIES-SPECIFIC SUSCEPTIBILITY OF CDNA-EXPRESSED CYP1A P-450S TO DIFFERENT FLAVONOIDS

      Biochimica et biophysica acta. Protein structure and molecular enzymology
    47. PENMAN BW; CHEN LP; GELBOIN HV; GONZALEZ FJ; CRESPI CL
      DEVELOPMENT OF A HUMAN LYMPHOBLASTOID CELL-LINE CONSTITUTIVELY EXPRESSING HUMAN CYP1A1 CDNA - SUBSTRATE-SPECIFICITY WITH MODEL SUBSTRATES AND PROMUTAGENS

      Carcinogenesis
    48. CHALOUPKA K; SANTOSTEFANO M; GOLDFARB IS; LIU G; MYERS MJ; TSYROLV IB; GELBOIN HV; KRISHNAN V; SAFE S
      ARYL-HYDROCARBON (AH) RECEPTOR-INDEPENDENT INDUCTION OF CYP1A2 GENE-EXPRESSION BY ACENAPHTHYLENE AND RELATED-COMPOUNDS IN B6C3F1 MICE

      Carcinogenesis
    49. THIRMAN MJ; ALBRECHT JH; KRUEGER MA; ERICKSON RR; CHERWITZ DL; PARK SS; GELBOIN HV; HOLTZMAN JL
      INDUCTION OF CYTOCHROME CYPIA1 AND FORMATION OF TOXIC METABOLITES OF BENZO[A]PYRENE BY RAT AORTA - A POSSIBLE ROLE IN ATHEROGENESIS

      Proceedings of the National Academy of Sciences of the United Statesof America
    50. OMATA Y; ROBINSON RC; GELBOIN HV; PINCUS MR; FRIEDMAN FK
      SPECIFICITY OF THE CYTOCHROME-P-450 INTERACTION WITH CYTOCHROME B(5)

      FEBS letters
    51. CZERWINSKI M; MCLEMORE TL; GELBOIN HV; GONZALEZ FJ
      QUANTIFICATION OF CYP2B7, CYP4B1, AND CYPOR MESSENGER-RNAS IN NORMAL HUMAN LUNG AND LUNG-TUMORS

      Cancer research
    52. SHOU M; GROGAN J; MANCEWICZ JA; KRAUSZ KW; GONZALEZ FJ; GELBOIN HV; KORZEKWA KR
      ACTIVATION OF CYP3A4 - EVIDENCE FOR THE SIMULTANEOUS BINDING OF 2 SUBSTRATES IN A CYTOCHROME-P450 ACTIVE-SITE

      Biochemistry
    53. NAKAJIMA T; WANG RS; ELOVAARA E; GONZALEZ FJ; GELBOIN HV; VAINIO H; AOYAMA T
      CYP2C11 AND CYP2B1 ARE MAJOR CYTOCHROME-P450 FORMS INVOLVED IN STYRENE OXIDATION IN LIVER AND LUNG MICROSOMES FROM UNTREATED RATS, RESPECTIVELY

      Biochemical pharmacology
    54. GELBOIN HV
      CYTOCHROME-P-450 - THE JAPANESE CONNECTION

      Japanese journal of cancer research
    55. BJELOGRLIC N; PENG RX; PARK SS; GELBOIN HV; HONKAKOSKI P; PELKONEN O; VAHAKANGAS K
      INVOLVEMENT OF P450 1A1 IN BENZO(A)PYRENE BUT NOT IN BENZO(A)PYRENE-7,8-DIHYDRODIOL ACTIVATION BY 3-METHYLCHOLANTHRENE-INDUCED MOUSE-LIVER MICROSOMES

      Pharmacology & toxicology
    56. FLAMMANG AM; GELBOIN HV; AOYAMA T; GONZALEZ FJ; MCCOY GD
      N-NITROSOPYRROLIDINE METABOLISM BY CDNA-EXPRESSED HUMAN CYTOCHROME-P-450S

      Biochemical archives
    57. HUANG Q; WANG S; CHEN SC; BABCOOK DM; PARK SS; GELBOIN HV; MIRVISH SS
      HYDROXYLATION AND DEALKYLATION OF METHYL-N-BUTYLNITROSAMINE AND ROLE OF CERTAIN CYTOCHROME-P-450 ISOZYMES IN THESE REACTIONS

      Cancer letters
    58. CRESPI CL; PENMAN BW; GONZALEZ FJ; GELBOIN HV; GALVIN M; LANGENBACH R
      GENETIC TOXICOLOGY USING HUMAN CELL-LINES EXPRESSING HUMAN P-450

      Biochemical Society transactions
    59. GONZALEZ FJ; GELBOIN HV
      ROLE OF HUMAN CYTOCHROME-P-450S IN RISK ASSESSMENT AND SUSCEPTIBILITYTO ENVIRONMENTALLY BASED DISEASE

      Journal of toxicology and environmental health
    60. MANI C; GELBOIN HV; PARK SS; PEARCE R; PARKINSON A; KUPFER D
      METABOLISM OF THE ANTIMAMMARY CANCER ANTIESTROGENIC AGENT TAMOXIFEN .1. CYTOCHROME P-450-CATALYZED N-DEMETHYLATION AND 4-HYDROXYLATION (VOL21, PG 645-656, 1993)

      Drug metabolism and disposition
    61. MANI C; GELBOIN HV; PARK SS; PEARCE R; PARKINSON A; KUPFER D
      METABOLISM OF THE ANTIMAMMARY CANCER ANTIESTROGENIC AGENT TAMOXIFEN .1. CYTOCHROME P-450-CATALYZED N-DEMETHYLATION AND 4-HYDROXYLATION

      Drug metabolism and disposition
    62. KIM ND; YOO JK; WON SM; PARK SS; GELBOIN HV
      PHENYTOIN INDUCTION OF CYTOCHROME P4502B IN MICE - EFFECTS ON HEXOBARBITAL HYDROXYLASE-ACTIVITY

      Xenobiotica
    63. GELBOIN HV
      CYTOCHROME-P450 AND MONOCLONAL-ANTIBODIES

      Pharmacological reviews
    64. TASSANEEYAKUL W; BIRKETT DJ; VERONESE ME; MCMANUS ME; TUKEY RH; QUATTROCHI LC; GELBOIN HV; MINERS JO
      SPECIFICITY OF SUBSTRATE AND INHIBITOR PROBES FOR HUMAN CYTOCHROMES-P450 1A1 AND 1A2

      The Journal of pharmacology and experimental therapeutics
    65. GOLDFARB I; KORZEKWA K; KRAUSZ KW; GONZALEZ F; GELBOIN HV
      CROSS-REACTIVITY OF 13 MONOCLONAL-ANTIBODIES WITH 10 VACCINA CDNA EXPRESSED RAT, MOUSE AND HUMAN CYTOCHROME-P450S

      Biochemical pharmacology
    66. WANG RS; NAKAJIMA T; PARK SS; GELBOIN HV; MURAYAMA N
      MONOCLONAL ANTIBODY-DIRECTED ASSESSMENT OF TOLUENE INDUCTION OF RAT HEPATIC CYTOCHROME-P450 ISOZYMES

      Biochemical pharmacology
    67. TSYRLOV IB; GOLDFARB IS; GELBOIN HV
      ENZYME-KINETIC AND IMMUNOCHEMICAL CHARACTERISTICS OF MOUSE CDNA-EXPRESSED, MICROSOMAL, AND PURIFIED CYP1A1 AND CYP1A2

      Archives of biochemistry and biophysics
    68. GONZALEZ FJ; CRESPI CL; CZERWINSKI M; GELBOIN HV
      ANALYSIS OF HUMAN CYTOCHROME-P450 CATALYTIC ACTIVITIES AND EXPRESSION

      Tohoku Journal of Experimental Medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/05/20 alle ore 04:08:22